Dijkstra BA - Search Results

1

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.

Carpentier PJ, de Jong CA, Dijkstra BA, Verbrugge CA, Krabbe PF. Carpentier PJ, et al. Among authors: dijkstra ba. Addiction. 2005 Dec;100(12):1868-74. doi: 10.1111/j.1360-0443.2005.01272.x. Addiction. 2005. PMID: 16367988 Clinical Trial.

2

Psychometric evaluation of the Dutch version of the Subjective Opiate Withdrawal Scale (SOWS).

Dijkstra BA, Krabbe PF, Riezebos TG, van der Staak CP, De Jong CA. Dijkstra BA, et al. Eur Addict Res. 2007;13(2):81-8. doi: 10.1159/000097937. Eur Addict Res. 2007. PMID: 17356279

3

Does naltrexone affect craving in abstinent opioid-dependent patients?

Dijkstra BA, De Jong CA, Bluschke SM, Krabbe PF, van der Staak CP. Dijkstra BA, et al. Addict Biol. 2007 Jun;12(2):176-82. doi: 10.1111/j.1369-1600.2007.00067.x. Addict Biol. 2007. PMID: 17508990

4

Prediction of withdrawal symptoms during opioid detoxification.

Dijkstra BA, Krabbe PF, De Jong CA, van der Staak CP. Dijkstra BA, et al. J Opioid Manag. 2008 Sep-Oct;4(5):311-9. doi: 10.5055/jom.2008.0035. J Opioid Manag. 2008. PMID: 19070269

5

Opioid detoxification: from controlled clinical trial to clinical practice.

Dijkstra BA, De Jong CA, Wensing M, Krabbe PF, van der Staak CP. Dijkstra BA, et al. Am J Addict. 2010 May-Jun;19(3):283-90. doi: 10.1111/j.1521-0391.2010.00033.x. Am J Addict. 2010. PMID: 20525037 Free article.

6

Prediction of abstinence in opioid-dependent patients.

Dijkstra BA, De Jong CA, Krabbe PF, van der Staak CP. Dijkstra BA, et al. J Addict Med. 2008;2(4):194-201. doi: 10.1097/ADM.0b013e31818a6596. J Addict Med. 2008. PMID: 21768990

7

Gamma-hydroxybutyrate detoxification by titration and tapering.

de Jong CA, Kamal R, Dijkstra BA, de Haan HA. de Jong CA, et al. Among authors: dijkstra ba. Eur Addict Res. 2012;18(1):40-5. doi: 10.1159/000333022. Epub 2011 Dec 3. Eur Addict Res. 2012. PMID: 22142784

8

[Detoxification of patients with GHB dependence].

de Weert-van Oene GH, Schellekens AF, Dijkstra BA, Kamal R, de Jong CA. de Weert-van Oene GH, et al. Among authors: dijkstra ba. Tijdschr Psychiatr. 2013;55(11):885-90. Tijdschr Psychiatr. 2013. PMID: 24242149 Free article. Dutch.

9

A case series of pharmaceutical gamma-hydroxybutyrate in 3 patients with severe benzodiazepine-resistant gamma-hydroxybutyrate withdrawal in the hospital.

van Noorden MS, Kamal RM, Dijkstra BA, Mauritz R, de Jong CA. van Noorden MS, et al. Among authors: dijkstra ba. Psychosomatics. 2015 Jul-Aug;56(4):404-9. doi: 10.1016/j.psym.2014.03.002. Epub 2014 Mar 12. Psychosomatics. 2015. PMID: 25016356 No abstract available.

10

The Effect of Co-occurring Substance Use on Gamma-hydroxybutyric Acid Withdrawal Syndrome.

Kamal RM, Dijkstra BA, Loonen AJ, De Jong CA. Kamal RM, et al. Among authors: dijkstra ba. J Addict Med. 2016 Jul-Aug;10(4):229-35. doi: 10.1097/ADM.0000000000000214. J Addict Med. 2016. PMID: 27310146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters